LeadIQ logo
Learn more at LeadIQ.com

Insights

Therapeutic Focus Immunocore is developing ImmTAX therapies for cancer, autoimmune, and infectious diseases, presenting sales opportunities in multiple healthcare sectors.

Strategic Partnerships Partnerships with Bristol-Myers Squibb and Delfi Diagnostics showcase credibility and potential collaboration avenues for sales growth in the biopharmaceutical industry.

Pipeline Expansion Continuous pipeline expansion, including new pre-clinical candidates for autoimmune diseases and launching products like KIMMTRAK, offers entry points for sales into emerging markets and treatments.

Financial Stability With revenue in the range of $50M - $100M and funding of $350M, Immunocore's financial standing indicates potential for large-scale sales deals and partnerships.

Market Positioning Being a pioneering commercial-stage biotechnology firm in TCR bispecific immunotherapies positions Immunocore strongly in the competitive landscape for sales and market penetration.

Immunocore Tech Stack

Immunocore uses 8 technology products and services including Linkedin Insight Tag, Skillsoft, Microsoft Word, and more. Explore Immunocore's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • Skillsoft
    Corporate Learning Management Systems
  • Microsoft Word
    Editors
  • GE Healthcare
    Healthcare Marketing
  • DataTables
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • Timesheets
    Time Tracking
  • Apache
    Web Servers

Media & News

Immunocore's Email Address Formats

Immunocore uses at least 1 format(s):
Immunocore Email FormatsExamplePercentage
first.last@immunocore.comJohn.Doe@immunocore.com
94%
f.last@immunocore.comJ.Doe@immunocore.com
3%
first@immunocore.comJohn@immunocore.com
2%
first.middle@immunocore.comJohn.Michael@immunocore.com
1%

Frequently Asked Questions

Where is Immunocore's headquarters located?

Minus sign iconPlus sign iconImmunocore's main headquarters is located at 101 Park Drive Milton Park Abingdon, Oxfordshire OX14 4RY GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Immunocore's phone number?

Minus sign iconPlus sign icon You can contact Immunocore's main corporate office by phone at +1-267-332-9176. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Immunocore's stock symbol?

Minus sign iconPlus sign iconImmunocore is a publicly traded company; the company's stock symbol is IMCR.

What is Immunocore's official website and social media links?

Minus sign iconPlus sign iconImmunocore's official website is immunocore.com and has social profiles on LinkedIn.

How much revenue does Immunocore generate?

Minus sign iconPlus sign icon As of May 2024, Immunocore's annual revenue reached $75M.

What is Immunocore's SIC code NAICS code?

Minus sign iconPlus sign iconImmunocore's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Immunocore have currently?

Minus sign iconPlus sign iconAs of May 2024, Immunocore has approximately 522 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Human Resources Officer: T. S. L.Chief Medical Officer And Head Of Clinical Development: M. M. D.Chief Operating Officer: J. T.. Explore Immunocore's employee directory with LeadIQ.

What industry does Immunocore belong to?

Minus sign iconPlus sign iconImmunocore operates in the Biotechnology Research industry.

What technology does Immunocore use?

Minus sign iconPlus sign iconImmunocore's tech stack includes Linkedin Insight TagSkillsoftMicrosoft WordGE HealthcareDataTablesAmazon Web ServicesTimesheetsApache.

What is Immunocore's email format?

Minus sign iconPlus sign iconImmunocore's email format typically follows the pattern of . Find more Immunocore email formats with LeadIQ.

How much funding has Immunocore raised to date?

Minus sign iconPlus sign icon As of May 2024, Immunocore has raised $350M in funding. The last funding round occurred on Jan 30, 2024.

When was Immunocore founded?

Minus sign iconPlus sign iconImmunocore was founded in 2008.
Immunocore

Immunocore

Biotechnology ResearchOxfordshire, United Kingdom201-500 Employees

Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. 

See our community guidelines: http://bit.ly/2kFA8hr

Section iconCompany Overview

Headquarters
101 Park Drive Milton Park Abingdon, Oxfordshire OX14 4RY GB
Phone number
+1-267-332-9176
Website
immunocore.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
IMCR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $350M

    Immunocore has raised a total of $350M of funding over 8 rounds. Their latest funding round was raised on Jan 30, 2024.

  • $50M$100M

    Immunocore's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $350M

    Immunocore has raised a total of $350M of funding over 8 rounds. Their latest funding round was raised on Jan 30, 2024.

  • $50M$100M

    Immunocore's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.